Biotricity, Inc. (BTCY) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Redwood City, CA, United States. Le PDG actuel est Waqaas Al-Siddiq.
BTCY a date d'introduction en bourse 2018-02-16, 55 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $7.68M.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
